Long-term visual outcome in idiopathic intracranial hypertension

Annals of Indian Academy of Neurology

Volumn 14, Issue 1, 2011, Pages 19-22

  Baheti, N ^a   Nair, M ^a   Thomas, S ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Fulminant IIH; idiopathic intracranial hypertension; pseudotumor cerebri

Indexed keywords

ACETAZOLAMIDE; FUROSEMIDE; STEROID;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID SHUNTING; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DIPLOPIA; DISEASE COURSE; DISEASE SEVERITY; EYE EXAMINATION; FOLLOW UP; HEADACHE; HUMAN; IDIOPATHIC DISEASE; INTRACRANIAL HYPERTENSION; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; VISION; VISUAL IMPAIRMENT;

EID: 79957553907     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.78044     Document Type: Article

References (14)

1. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002;59:1492-5. (Pubitemid 35387052)
2. Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O'Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 1993;50:78-80.
3. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol 1988;45:875-7.
4. Digre KB, Corbett JJ. Idiopathic intracranial hypertension (pseudotumor cerebri): a reappraisal. Neurologist 2001;7:2-67. (Pubitemid 32095779)
5. Rowe FJ, Sarkies NJ. Assessment of visual function in idiopathic intracranial hypertension: a prospective study. Eye 1988;12:111-8.
6. Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology 2004;63:1737-9. (Pubitemid 39507606)
7. Arienta C, Caroli M, Balbi S, Parma A, Calappi E, Massei R. Clinical evaluation and long-term follow-up in 16 patients with pseudotumour cerebri. Acta Neurochir Suppl 1990;51:369-71.
8. Shah VA, Kardon RH, Lee AG, Corbett JJ, Wall M. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology 2008;70:634-40. (Pubitemid 351294641)
9. Wall M, George D. Visual loss in pseudotumor cerebri: incidence and defects related to visual field strategy. Arch Neurol 1987;44:170-5. (Pubitemid 17002600)
10. Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982;39:461-74.
11. Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology 2007;68;229-232. (Pubitemid 46105743)
12. Cleary PA, Beck RW, Bourque LB. Visual symptoms after optic neuritis: results from the Optic Neuritis Treatment Trial. J Neuroophthalmol 1997;17:1-28.
13. Rush JA. Pseudotumor cerebri. Clinical profile and visual outcome in 63 patients. Mayo Clin Proc 1980;55:541-6.
14. Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007;143:635-41.